Processa Pharmaceuticals Inc (PCSA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 5,571 | 8,920 | 4,706 | 6,861 | 8,677 |
| Other current assets | 0 | 22 | 0 | 0 | 0 |
| TOTAL | $7,478 | $9,800 | $5,633 | $7,908 | $9,897 |
| Non-Current Assets | |||||
| PPE Net | 2 | 2 | 3 | 3 | N/A |
| Other Non-Current Assets | 121 | 142 | 152 | 173 | 193 |
| TOTAL | $123 | $144 | $154 | $175 | $193 |
| Total Assets | $7,601 | $9,945 | $5,787 | $8,083 | $10,090 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 953 | 455 | 312 | 346 | 239 |
| Accrued Expenses | 505 | 466 | 146 | 202 | 312 |
| Other current liabilities | N/A | N/A | 189 | 195 | 189 |
| TOTAL | $1,552 | $1,011 | $731 | $826 | $821 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 26 | 51 | 67 | 89 | 109 |
| TOTAL | $26 | $51 | $67 | $89 | $109 |
| Total Liabilities | $1,577 | $1,061 | $798 | $915 | $931 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 3,257 | 2,858 | 2,856 | 1,232 | 1,227 |
| Common Shares | 0 | 0 | 0 | 3 | 3 |
| Retained earnings | -81,106 | -78,096 | -75,369 | -72,964 | -70,882 |
| Other shareholders' equity | -300 | -300 | -300 | -300 | -300 |
| TOTAL | $6,024 | $8,883 | $4,989 | $7,168 | $9,160 |
| Total Liabilities And Equity | $7,601 | $9,945 | $5,787 | $8,083 | $10,090 |